blinkcns.com

What It Is

Blinkcns is not a traditional general-purpose SaaS product, but a neurological assessment solution combining medical device hardware, a mobile app, and cloud-based AI analysis. Its EyeStat5 follows the FDA-cleared EyeStat technology pathway, using the blink reflex to collect ocular data within 30 seconds for the management of neurological conditions and the assessment of abnormalities related to TBI/concussion, Parkinson’s disease, and more. The system is designed for clinical settings and can also be extended to sports facilities, telehealth, or at-home testing.

Core Features and Technology

EyeStat5 requires an iPhone or Android mobile device to be placed inside a head-mounted device, using the camera to record the test. During the test, a gentle puff of air is randomly directed at the corner of the eye to trigger the blink reflex, capturing more than 7,000 eye images within 30 seconds. The data is then sent to blinkcns’s AWS cloud, where its patented ML/AI software analyzes it and generates objective, measurable blink parameters. Clinicians can view the results through a HIPAA-compliant portal. The website emphasizes accurate and reliable results, real-time feedback, comprehensive reports, portability, and the ability to fit into existing assessment workflows.

Pricing, Trial, and Integrations

The official website does not disclose hardware pricing, subscription fees, plan tiers, or payment methods. It only provides options to contact a specialist or schedule a demo. The FAQ states that users can contact the company directly to try EyeStat5, but it does not specify the trial period or conditions. For integrations, the site only says the product can be seamlessly incorporated into existing assessment workflows, without listing EHR/EMR support, third-party medical systems, APIs, SDKs, or developer documentation. Before enterprise procurement, buyers should pay close attention to data interfaces, hospital information system integration, and deployment boundaries.

Security, Compliance, and Deployment

Blinkcns explicitly mentions HIPAA-compliant access to medical records, data management, and a clinical portal, with cloud-based analysis running on the blinkcns AWS cloud. It does not mention self-hosting, on-premises deployment, SOC 2, ISO 27001, or other compliance certifications. For healthcare institutions, HIPAA is an important baseline, but cross-border use still requires further assessment of data transfer, patient privacy, and local medical device regulatory requirements.

Pros, Cons, and Best-Fit Users

Its strengths are that testing is fast, non-invasive, and places a low cognitive burden on patients, while providing more objective physiological parameters than subjective rating scales. Its portable form factor also makes it suitable for sports medicine, concussion management, neurology follow-ups, and remote assessment. The drawbacks are opaque pricing, no current reimbursement coverage, and contraindications such as a history of epilepsy, eye infection, and narrow-angle glaucoma. Information on open integrations and permission-based collaboration is also limited. It is better suited to hospitals, sports teams, universities, and medical institutions with clinical research or specialized neurological assessment needs, rather than general business software users.

Access in China and Alternatives

The main content does not provide information on network access from China, RMB payments, Chinese-language support, or local registration, so china_access can only be considered unknown. For deployment in China, medical device registration, data compliance, cross-border cloud access, and after-sales support should be carefully verified. Alternative categories to consider include domestic suppliers of eye-tracking systems, concussion assessment tools, neurorehabilitation evaluation solutions, and hospital digital diagnostic equipment.